Hypertrophy of the Heart: A New Therapeutic Target?

Norbert Frey, Hugo A. Katus, Eric N Olson, Joseph A Hill

Research output: Contribution to journalArticle

554 Citations (Scopus)

Abstract

Recent studies call into question the necessity of hypertrophic growth of the heart as a "compensatory" response to hemodynamic stress. These findings, coupled with recent progress in dissecting the molecular bases of hypertrophy, raise the prospect of suppressing hypertrophy without provoking circulatory insufficiency. In this article, we focus on signaling pathways that hold promise as potential targets for therapeutic intervention. We also summarize observations from animal models and clinical trials that suggest benefit from an antihypertrophic strategy.

Original languageEnglish (US)
Pages (from-to)1580-1589
Number of pages10
JournalCirculation
Volume109
Issue number13
DOIs
StatePublished - Apr 6 2004

Fingerprint

Cardiomegaly
Hypertrophy
Animal Models
Hemodynamics
Clinical Trials
Therapeutics
Growth

Keywords

  • Heart failure
  • Hypertrophy
  • Signal transduction

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Hypertrophy of the Heart : A New Therapeutic Target? / Frey, Norbert; Katus, Hugo A.; Olson, Eric N; Hill, Joseph A.

In: Circulation, Vol. 109, No. 13, 06.04.2004, p. 1580-1589.

Research output: Contribution to journalArticle

Frey, Norbert ; Katus, Hugo A. ; Olson, Eric N ; Hill, Joseph A. / Hypertrophy of the Heart : A New Therapeutic Target?. In: Circulation. 2004 ; Vol. 109, No. 13. pp. 1580-1589.
@article{79385dcfa1514c4e899d71f685e1768a,
title = "Hypertrophy of the Heart: A New Therapeutic Target?",
abstract = "Recent studies call into question the necessity of hypertrophic growth of the heart as a {"}compensatory{"} response to hemodynamic stress. These findings, coupled with recent progress in dissecting the molecular bases of hypertrophy, raise the prospect of suppressing hypertrophy without provoking circulatory insufficiency. In this article, we focus on signaling pathways that hold promise as potential targets for therapeutic intervention. We also summarize observations from animal models and clinical trials that suggest benefit from an antihypertrophic strategy.",
keywords = "Heart failure, Hypertrophy, Signal transduction",
author = "Norbert Frey and Katus, {Hugo A.} and Olson, {Eric N} and Hill, {Joseph A}",
year = "2004",
month = "4",
day = "6",
doi = "10.1161/01.CIR.0000120390.68287.BB",
language = "English (US)",
volume = "109",
pages = "1580--1589",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - Hypertrophy of the Heart

T2 - A New Therapeutic Target?

AU - Frey, Norbert

AU - Katus, Hugo A.

AU - Olson, Eric N

AU - Hill, Joseph A

PY - 2004/4/6

Y1 - 2004/4/6

N2 - Recent studies call into question the necessity of hypertrophic growth of the heart as a "compensatory" response to hemodynamic stress. These findings, coupled with recent progress in dissecting the molecular bases of hypertrophy, raise the prospect of suppressing hypertrophy without provoking circulatory insufficiency. In this article, we focus on signaling pathways that hold promise as potential targets for therapeutic intervention. We also summarize observations from animal models and clinical trials that suggest benefit from an antihypertrophic strategy.

AB - Recent studies call into question the necessity of hypertrophic growth of the heart as a "compensatory" response to hemodynamic stress. These findings, coupled with recent progress in dissecting the molecular bases of hypertrophy, raise the prospect of suppressing hypertrophy without provoking circulatory insufficiency. In this article, we focus on signaling pathways that hold promise as potential targets for therapeutic intervention. We also summarize observations from animal models and clinical trials that suggest benefit from an antihypertrophic strategy.

KW - Heart failure

KW - Hypertrophy

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=1842579393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842579393&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000120390.68287.BB

DO - 10.1161/01.CIR.0000120390.68287.BB

M3 - Article

C2 - 15066961

AN - SCOPUS:1842579393

VL - 109

SP - 1580

EP - 1589

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 13

ER -